Sildenafil benefit small in patients with idiopathic pulmonary fibrosis
Wednesday, September 22, 2010 - 08:21
in Health & Medicine
Sildenafil failed to significantly increase exercise capacity, but did improve arterial oxygenation, shortness of breath and quality of life in patients with advanced idiopathic pulmonary fibrosis (IPF), in the first randomized trial of the medication for IPF. The study is published in the August 12, 2010, issue of the New England Journal of Medicine.
